March 22, 2026

FDA Drug Safety Communication: Serious skin reactions after combination treatment with the Hepatitis C drugs Incivek (telaprevir), peginterferon alfa, and ribavirin

Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary  Safety Announcement [12-19-2012] The U.S. Food and Drug Administration (FDA) received reports of serious skin reactions, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0